Webinars
Deep dive into Neuromodulation: What can 2mA really do?
An exclusive look at how Professor Alex ONeill-Kerr utilises TMS and tDCS. During this 60min webinar, hear more about his experiences using Flow in his private practice and the following topics:
- Key differences between TMS and tDCS
- Innovative approaches for enhanced patient outcomes
- Real-world patient examples
- Open Q&A session
This webinar is intended for educational use only. Also available here.
Flow in the Private Practice
Hear directly from Dr. Hannah Nearney and Dr. Kultar Garcha as they share their first-hand experiences with integrating Flow Neuroscience into their private practices and patient care strategies. Delving into topics such as:
- What aspects of Flow they find most beneficial in their practice
- Why they have chosen to incorporate Flow into their treatment protocols
- Patient demographics they have successfully treated with Flow
- Open Q&A session
This webinar offers invaluable insights into the practical applications of Flow Neuroscience, directly from those who have witnessed its impact in clinical settings. Also available here.
Contraindications and side-effects of Flow
Flow Neuroscience's Global Medical Director, Dr. Kultar Garcha, provides an update regarding Flow's contraindications, warnings, and side-effects. Watch this webinar to learn more on: Specifically:
- tDCS side-effects from the literature and clinical trial
- Flow side-effects from real-world data
- What's changed with Flow's contraindications and warnings?
Flow and the NHS
Flow Neuroscience's Head of Growth, Sam Lowden, alongside Flow Neuroscience's NHS Liasion Lead, Alexis Besson, provide a deep-dive into everything related to Flow and the NHS:
- Dive into results from ongoing primary care, perinatal and CMHT pilots
- Hear clinician and patient feedback
- Overview of recent NICE MIB324
- Upcoming opportunities
- Open Q&A
Overview of long-term usage and Flow treatment schedules
Flow Neuroscience's Clinical Lead, Hanna Silva, shares insights about Flow's stimulation schedule and long-term usage. Specifically:
- Overview of the Flow treatment schedule
- What does the evidence say about long-term usage of tDCS?
- Alternative stimulation schedule recommendations
- Open Q&A
EMPOWER trial interim results review
Hear directly from Flow Neuroscience Chief Clinical Officer and Founder, Daniel Månsson, in an exclusive webinar to learn more about Flow's recent clinical trial. Specifically:
- Overview and summary of the initial results from the EMPOWER clinical trial
- Review what these results mean for your patients and your practice